US 6258845
DFMO and sulindac combination in cancer chemoprevention
expired A61KA61K31/19A61K31/195
Quick answer
US patent 6258845 (DFMO and sulindac combination in cancer chemoprevention) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Jul 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Arizona Board of Regents on Behalf of the University of Arizona
- Grant date
- Tue Jul 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/19, A61K31/195, A61P, A61P35/00